http://bit.ly/2V9MHy7 support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:50AM
Tuesday, February 19, 2019
UPDATE 1-Teva expects about 25 pct of EpiPen market by year-end
Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPen to have about 25 percent of the U.S. market by the end of 2019, Chief Executive Kare Schultz said on Tuesday.
http://bit.ly/2V9MHy7 support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:50AM
http://bit.ly/2V9MHy7 support@endlesssupplies.biz (Endless Supplies .Biz) February 19, 2019 at 04:50AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment